KARI MOORHEAD: Open Payments
NPI 1811291362 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 17 payments from 10 companies in 2025. Trend: 2023 $21 · 2024 $57 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $107 |
| Janssen Biotech, Inc. | 3 | $70 |
| ABBVIE INC. | 3 | $59 |
| LEO Pharma Inc. | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| GENZYME CORPORATION | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $17 |
Products named: Bimzelx, TREMFYA, DUPIXENT, ANZUPGO, RINVOQ, TALTZ, SKYRIZI, COSENTYX.
Industry payments across NY — which companies pay providers there.
